Healthcare Market Analysis, Healthcare Market Growth Analysis-Ken Research

1
Advancements In Stem Cell Research Market
Outlook-Ken Research
2
Advancements in medicine have led us to a time
where there are options available to regenerate
organs. Stem cell surgery is the use of stem
cells to treat ailments and is gaining popularity
for its ability to regenerate body tissue.
Healthcare market research report consulting
shows that it already has wide ranged uses in
orthopedics, blood cell formation and brain and
spinal cord injuries. Its application on the
heart is also being extensively researched. Heart
failure occurs when the heart does not pump
sufficient blood to maintain bodily
functions. Heart Failure is a chronic disease
needing lifelong management however, with
treatment signs and symptoms can improve even
making the heart stronger sometimes thereby
helping you live longer and reducing your chance
of dying suddenly. Doctors can sometimes correct
heart failure by treating the underlying cause
for example repairing a heart valve or
controlling a fast heart rhythm may reverse heart
failure. For most people though, treatment of
heart failure involves a balance of the right
medications and in some cases use of devices that
help the heart beat and contract properly. Now a
new research is being carried out to augment the
use of stem cells in the process of treatment.
Clinical trial planning is underway at US based
MedStar Heart Vascular Institute to determine
whether novel stem cell therapy will improve
heart function for patients with heart failure.
The trial will use CardioCells proprietary
Mesenchymal Stem Cells (MSCs) manufactured by
Stemedica. The goal is to improve outcomes in
patients with heart failure and left ventricular
assist devices (LVADs).
3
This research is a leap forward not only from the
medical science perspective but also from a
business standpoint. Healthcare business review
indicates that the global stem cell market is
expected to reach nearly USD 16 billion by 2025
growing at a CAGR of 9.4 approximately. This
research has led to the partnership of three
highly reputed US based institutions. MedStar
Heart Vascular Institute is a national leader
in research, diagnosis and treatment of
cardiovascular disease and has been consistently
ranked as one of the premier destinations for
cardiac care in the region for more than 55
years. Stemedica Cell Technologies is a global
leader in regenerative medicine that develops,
manufactures and distributes adult allogeneic
stem cell products and houses more than 30
years of research and innovation. CardioCell is a
global biotechnology company that explores
therapeutic applications of stem cells and has an
exclusive worldwide license from Stemedica Cell
Technologies for the exploration of therapeutic
cardiovascular indications including Chronic
Heart Failure (CHF). This research also proves
that stem cells are gaining global interests.
Stem cells are being used as building blocks for
humans that are not only benefiting medical
science by increasing its scope but also paving
the way for further research and discoveries. Big
medical companies are actively investing in the
bright future of stem cells and this is evident
by the research project being carried out by
MedStar Heart Vascular Institute.
Technologically advanced countries are constantly
attempting to increase the utility from stem cell
products which is the main growth driver with the
US being at the forefront of this movement.
4
To know more, click on the link
below https//www.kenresearch.com/healthcare/gene
ral-healthcare/SC-91-64.html Related
Report https//www.kenresearch.com/healthcare/med
ical-devices/india-healthcare-it-market-research-r
eport/527-91.html Contact Us Ken Research Ankur
Gupta, Head Marketing Communications sales_at_kenre
search.com 91-9015378249
5
(No Transcript)